695127AD2
Pacira Biosciences, Inc.
Could not find a ticker for this position, may be a filing error
Pacira BioSciences makes non-opioid pain treatments, best known for EXPAREL, a long-acting local anesthetic injected at the surgical site so patients recover from operations with less reliance on opioids. Its lineup also includes iovera°, a device that uses targeted cold to numb nerves. Founded in 2006 under the placeholder name Blue Acquisition Corp., the Tampa-based company later renamed itself Pacira and rebranded as Pacira BioSciences in 2019.
CONVERTIBLEUnderlying: PCRXCUSIP: 695127AD2HealthcareUS1 derivative reporter
2.375% Convertible Senior Notes due April 1, 2022
No tracked superinvestor held this security as stock in this period — only the derivative positions below reference it.
Derivative Reporters
Investor
Kind
13F reported value
Quantity
Change
